SubjectVerb relationObjectSentenceSentimentTitleUrlDate
list price of per unit set by Coherus is same as Mylan NVs biosimilar Fulphila that was approved earlier this year The list price of per unit set by Coherus is the same as Mylan NVs biosimilar Fulphila that was approved earlier this year NegativeCoherus BioSciences Inc said on Thursday it would price its biosimilar to Amgen Incs infectionfighting treatment Neulasta at a 33 percent discount http://www.reuters.com/news/health/article/us-coherus-biosimilar/coherus-prices-biosimilar-to-amgens-neulasta-at-33-percent-discount-idUSKCN1ND36Q2018-11-09